# Pharmacogentic Screening of Coumarine Based Oral Anticoagulant Using Next Generation Seguencer

> **NCT03180567** · NA · UNKNOWN · sponsor: **Tanta University** · enrollment: 20 (estimated)

## Conditions studied

- Thrombosis

## Interventions

- **DIAGNOSTIC_TEST:** Genetic Mutations

## Key facts

- **NCT ID:** NCT03180567
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-06-06
- **Primary completion:** 2020-12
- **Final completion:** 2020-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2017-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03180567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03180567, "Pharmacogentic Screening of Coumarine Based Oral Anticoagulant Using Next Generation Seguencer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03180567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*